Daan Gene Statistics

Total Valuation

Daan Gene has a market cap or net worth of CNY 8.10 billion. The enterprise value is 7.35 billion.

Market Cap	8.10B
Enterprise Value	7.35B

Important Dates

The last earnings date was Friday, April 3, 2026.

Earnings Date	Apr 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Daan Gene has 1.40 billion shares outstanding. The number of shares has decreased by -4.97% in one year.

Current Share Class	1.40B
Shares Outstanding	1.40B
Shares Change (YoY)	-4.97%
Shares Change (QoQ)	-2.48%
Owned by Insiders (%)	2.02%
Owned by Institutions (%)	7.22%
Float	931.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.97
PB Ratio	1.11
P/TBV Ratio	1.22
P/FCF Ratio	84.81
P/OCF Ratio	26.08
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.21
EV / Sales	9.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	77.01

Financial Position

The company has a current ratio of 2.98, with a Debt / Equity ratio of 0.02.

Current Ratio	2.98
Quick Ratio	1.97
Debt / Equity	0.02
Debt / EBITDA	15.56
Debt / FCF	1.37
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -12.03% and return on invested capital (ROIC) is -10.56%.

Return on Equity (ROE)	-12.03%
Return on Assets (ROA)	-1.97%
Return on Invested Capital (ROIC)	-10.56%
Return on Capital Employed (ROCE)	-3.80%
Weighted Average Cost of Capital (WACC)	6.14%
Revenue Per Employee	426,569
Profits Per Employee	-517,606
Employee Count	1,730
Asset Turnover	0.08
Inventory Turnover	2.85

Taxes

Income Tax	-20.68M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.22% in the last 52 weeks. The beta is 0.36, so Daan Gene's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	+7.22%
50-Day Moving Average	6.04
200-Day Moving Average	6.42
Relative Strength Index (RSI)	40.61
Average Volume (20 Days)	11,305,647

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daan Gene had revenue of CNY 737.96 million and -895.46 million in losses. Loss per share was -0.63.

Revenue	737.96M
Gross Profit	238.97M
Operating Income	-281.20M
Pretax Income	-950.66M
Net Income	-895.46M
EBITDA	-2.13M
EBIT	-281.20M
Loss Per Share	-0.63

Full Income Statement

Balance Sheet

The company has 1.10 billion in cash and 130.55 million in debt, giving a net cash position of 971.84 million or 0.69 per share.

Cash & Cash Equivalents	1.10B
Total Debt	130.55M
Net Cash	971.84M
Net Cash Per Share	0.69
Equity (Book Value)	7.27B
Book Value Per Share	5.02
Working Capital	1.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 310.55 million and capital expenditures -215.06 million, giving a free cash flow of 95.49 million.

Operating Cash Flow	310.55M
Capital Expenditures	-215.06M
Depreciation & Amortization	334.66M
Net Borrowing	-19.40M
Free Cash Flow	95.49M
FCF Per Share	0.07

Full Cash Flow Statement

Margins

Gross margin is 32.38%, with operating and profit margins of -38.10% and -121.34%.

Gross Margin	32.38%
Operating Margin	-38.10%
Pretax Margin	-128.82%
Profit Margin	-121.34%
EBITDA Margin	-0.29%
EBIT Margin	-38.10%
FCF Margin	12.94%

Dividends & Yields

Daan Gene does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.97%
Shareholder Yield	4.97%
Earnings Yield	-11.06%
FCF Yield	1.18%

Dividend Details

Stock Splits

The last stock split was on May 19, 2021. It was a forward split with a ratio of 1.6.

Last Split Date	May 19, 2021
Split Type	Forward
Split Ratio	1.6

Scores

Altman Z-Score	n/a
Piotroski F-Score	3